Regeneron has announced a strategic research collaboration with Parabilis Medicines to discover and develop multiple ...
GSK has signed a new three-year agreement with Protas that aims to streamline trials across several core therapeutic areas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results